Transplantation tolerance: the big picture. Where do we stand, where should we go?
A major goal in organ transplantation has been to safely exploit the natural processes of immune tolerance in order to minimize the dose and duration of drug immunosuppression. In this commentary, I argue that we can learn from how tumours avoid rejection, to evolve a three-stage tolerance-inducing...
Auteur principal: | Waldmann, H |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Wiley
2017
|
Documents similaires
-
Transplantation tolerance-where do we stand?
par: Waldmann, H
Publié: (1999) -
Mesenchymal Stromal Cells’ Therapy for Polyglutamine Disorders: Where Do We Stand and Where Should We Go?
par: Inês Barros, et autres
Publié: (2020-10-01) -
Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
par: Aqeel M. Alenazi, et autres
Publié: (2023-04-01) -
ColVI myopathies: where do we stand, where do we go?
par: Allamand Valérie, et autres
Publié: (2011-09-01) -
Training Needs Assessment: Where We Are and Where We Should Go
par: Rodrigo Rezende Ferreira, et autres
Publié: (2013-01-01)